<VariationArchive VariationID="4722" VariationName="NM_015166.4(MLC1):c.135dup (p.Cys46fs)" VariationType="Duplication" Accession="VCV000004722" Version="22" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19761" VariationID="4722">
      <GeneList>
        <Gene Symbol="MLC1" FullName="modulator of VRAC current 1" GeneID="23209" HGNC_ID="HGNC:17082" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50059391" stop="50085875" display_start="50059391" display_stop="50085875" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="50497819" stop="50524357" display_start="50497819" display_stop="50524357" Strand="-" />
          </Location>
          <OMIM>605908</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015166.4(MLC1):c.135dup (p.Cys46fs)</Name>
      <CanonicalSPDI>NC_000022.11:50084767:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50084767" stop="50084768" display_start="50084767" display_stop="50084768" variantLength="1" positionVCF="50084767" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="50523196" stop="50523197" display_start="50523196" display_stop="50523197" variantLength="1" positionVCF="50523196" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>C46fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.50523202dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.50523202dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.50084773dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.50084773dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009162.1" sequenceAccession="NG_009162" sequenceVersion="1" change="g.6162dup">
            <Expression>NG_009162.1:g.6162dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376472.1" sequenceAccession="NM_001376472" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376472.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363401.1" sequenceAccession="NP_001363401" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363401.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376473.1" sequenceAccession="NM_001376473" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376473.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363402.1" sequenceAccession="NP_001363402" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363402.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376474.1" sequenceAccession="NM_001376474" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376474.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363403.1" sequenceAccession="NP_001363403" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363403.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376475.1" sequenceAccession="NM_001376475" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376475.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363404.1" sequenceAccession="NP_001363404" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363404.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376476.1" sequenceAccession="NM_001376476" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376476.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363405.1" sequenceAccession="NP_001363405" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363405.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376477.1" sequenceAccession="NM_001376477" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376477.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363406.1" sequenceAccession="NP_001363406" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363406.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376478.1" sequenceAccession="NM_001376478" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376478.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363407.1" sequenceAccession="NP_001363407" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363407.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376479.1" sequenceAccession="NM_001376479" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376479.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363408.1" sequenceAccession="NP_001363408" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363408.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376480.1" sequenceAccession="NM_001376480" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376480.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363409.1" sequenceAccession="NP_001363409" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363409.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376481.1" sequenceAccession="NM_001376481" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376481.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363410.1" sequenceAccession="NP_001363410" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363410.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376482.1" sequenceAccession="NM_001376482" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376482.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363411.1" sequenceAccession="NP_001363411" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363411.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376483.1" sequenceAccession="NM_001376483" sequenceVersion="1" change="c.135dup">
            <Expression>NM_001376483.1:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363412.1" sequenceAccession="NP_001363412" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_001363412.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015166.4" sequenceAccession="NM_015166" sequenceVersion="4" change="c.135dup" MANESelect="true">
            <Expression>NM_015166.4:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055981.1" sequenceAccession="NP_055981" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_055981.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139202.3" sequenceAccession="NM_139202" sequenceVersion="3" change="c.135dup">
            <Expression>NM_139202.3:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_631941.1" sequenceAccession="NP_631941" sequenceVersion="1" change="p.Cys46fs">
            <Expression>NP_631941.1:p.Cys46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164811.1" sequenceAccession="NR_164811" sequenceVersion="1" change="n.482dup">
            <Expression>NR_164811.1:n.482dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164812.1" sequenceAccession="NR_164812" sequenceVersion="1" change="n.266dup">
            <Expression>NR_164812.1:n.266dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164813.1" sequenceAccession="NR_164813" sequenceVersion="1" change="n.659dup">
            <Expression>NR_164813.1:n.659dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376484.1" sequenceAccession="NM_001376484" sequenceVersion="1" change="c.-59+587dup">
            <Expression>NM_001376484.1:c.-59+587dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139202.3" sequenceAccession="NM_139202" sequenceVersion="3" change="c.135dupC">
            <Expression>NM_139202.3:c.135dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015166.3" sequenceAccession="NM_015166" sequenceVersion="3" change="c.135dupC">
            <Expression>NM_015166.3:c.135dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015166.4" sequenceAccession="NM_015166" sequenceVersion="4" change="c.135dupC" MANESelect="true">
            <Expression>NM_015166.4:c.135dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340285" DB="ClinGen" />
        <XRef ID="GTR000556570" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="605908.0011" DB="OMIM" />
        <XRef Type="rs" ID="80358241" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015166.4(MLC1):c.135dup (p.Cys46fs) AND Megalencephalic leukoencephalopathy with subcortical cysts 1" Accession="RCV000004987" Version="19">
        <ClassifiedConditionList TraitSetID="1294">
          <ClassifiedCondition DB="MedGen" ID="C5779875">Megalencephalic leukoencephalopathy with subcortical cysts 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-17" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015166.4(MLC1):c.135dup (p.Cys46fs) AND not provided" Accession="RCV000599600" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-11" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015166.4(MLC1):c.135dup (p.Cys46fs) AND Megalencephalic leukoencephalopathy with subcortical cysts" Accession="RCV001274276" Version="1">
        <ClassifiedConditionList TraitSetID="10443">
          <ClassifiedCondition DB="MedGen" ID="C1858854">Megalencephalic leukoencephalopathy with subcortical cysts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-17" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11254442</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11935341</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12189496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14572144</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15037685</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16470554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21555057</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22006981</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24824219</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301707</ID>
          <ID Source="BookShelf">NBK1535</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1294" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5464" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Megalencephalic leukoencephalopathy with subcortical cysts 1</ElementValue>
                <XRef ID="MONDO:0024555" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vacuolating megalencephalic leukoencephalopathy with subcortical cysts</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Megalencephaly-cystic leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy with swelling and cysts</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MLC1</ElementValue>
                <XRef ID="GTR000559496" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604004" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VL</ElementValue>
                <XRef Type="MIM" ID="604004" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The classic phenotype of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in virtually all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to and usually several centimeters above the 98th centile. Initial mental and motor development is normal in most individuals. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Almost all individuals have epilepsy from an early age. The epilepsy is typically well controlled with anti-seizure medication, but status epilepticus occurs relatively frequently. Mental deterioration is late and mild. Disease severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their fifties. An improving phenotype has a similar initial presentation with delayed mental or motor development, followed by an improving clinical course: macrocephaly usually persists, but some children become normocephalic; motor function improves or normalizes; hypotonia and clumsiness may persist in some or neurologic examination may become normal. Some have intellectual disability that is stable, with or without autism. Epilepsy and status epilepticus may occur.</Attribute>
                <XRef ID="NBK1535" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301707</ID>
                <ID Source="BookShelf">NBK1535</ID>
              </Citation>
              <XRef ID="2478" DB="Orphanet" />
              <XRef ID="C5779875" DB="MedGen" />
              <XRef ID="MONDO:0024555" DB="MONDO" />
              <XRef Type="MIM" ID="604004" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10443" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17941" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VAN DER KNAAP DISEASE</ElementValue>
                <XRef Type="MIM" ID="604004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Megalencephalic leukoencephalopathy with subcortical cysts</ElementValue>
                <XRef ID="Megalencephalic+leukoencephalopathy+with+subcortical+cysts/4559" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011391" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LVM</ElementValue>
                <XRef Type="MIM" ID="604004" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MLC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3445" />
                <XRef ID="3445" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The classic phenotype of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in virtually all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to and usually several centimeters above the 98th centile. Initial mental and motor development is normal in most individuals. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Almost all individuals have epilepsy from an early age. The epilepsy is typically well controlled with anti-seizure medication, but status epilepticus occurs relatively frequently. Mental deterioration is late and mild. Disease severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their fifties. An improving phenotype has a similar initial presentation with delayed mental or motor development, followed by an improving clinical course: macrocephaly usually persists, but some children become normocephalic; motor function improves or normalizes; hypotonia and clumsiness may persist in some or neurologic examination may become normal. Some have intellectual disability that is stable, with or without autism. Epilepsy and status epilepticus may occur.</Attribute>
                <XRef ID="NBK1535" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301707</ID>
                <ID Source="BookShelf">NBK1535</ID>
              </Citation>
              <XRef ID="2478" DB="Orphanet" />
              <XRef ID="C1858854" DB="MedGen" />
              <XRef ID="MONDO:0011391" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25163" SubmissionDate="2016-09-28" DateLastUpdated="2016-10-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605908.0011_MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1" title="MLC1, 1-BP INS, 135C_MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1" />
        <ClinVarAccession Accession="SCV000025163" DateUpdated="2016-10-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient of Indian Agrawali ancestry with megalencephalic leukoencephalopathy with subcortical cysts (MLC1; 604004), Ben-Zeev et al. (2002) identified a homozygous insertion of a cytosine at nucleotide 135 at exon 2 of the MLC1 gene. This resulted in a frameshift and the creation of a stop codon 104 bp downstream.</Attribute>
              <Citation>
                <ID Source="PubMed">12189496</ID>
              </Citation>
              <XRef DB="OMIM" ID="604004" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Leegwater et al. (2002) described this mutation in 3 Agrawali patients. They stated that the disease was probably introduced into the tribe by a single founder, and the mutation is probably shared by all MLC patients of this community.</Attribute>
              <Citation>
                <ID Source="PubMed">11935341</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1" />
          </GeneList>
          <Name>MLC1, 1-BP INS, 135C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 135C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605908.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41274" SubmissionDate="2022-08-24" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_015166.3:c.135dupC|MedGen:CN034246" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000041274" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11935341</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14572144</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15037685</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.3:c.135dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN034246" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11967602</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7125644" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="5ca79aadbfc6731ad1f7a964762d76befd25854bab5da79128a7b4f1594bf97f|OMIM:604004" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003821540" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.3:c.135dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604004" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1390393" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1890743|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710387" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.135dupC variant in the MLC1 gene has been reported in the homozygous state in several unrelated patients with MLC (Leegwater et al., 2002; Ben-Zeev et al., 2002; Ridder et al., 2011; Saini et al., 2015). The c.135dupC variant causes a frameshift starting with codon Cysteine 46, changes this amino acid to a Leucine residue, and creates a premature Stop codon at position 34 of the new reading frame, denoted p.Cys46LeufsX34. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.135dupC variant is observed in 7/245210 (0.003%) alleles in large population cohorts We interpret c.135dupC as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="GG" referenceAllele="G" start="50523196" stop="50523197" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.3:c.135dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354508" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="547|OMIM:604004" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194053" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000677903" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000677903 was merged into SCV001194053 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15037685</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14572144</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22006981</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12189496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11935341</ID>
          </Citation>
          <Comment>NM_015166.3(MLC1):c.135dupC(aka C46Lfs*34) is classified as pathogenic in the context of megalencephalic leukoencephalopathy with subcortical cysts. Sources cited for classification include the following: PMID 15037685, 14572144, 22006981, 12189496 and 11935341. Classification of NM_015166.3(MLC1):c.135dupC(aka C46Lfs*34) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="AG" referenceAllele="A" start="50523196" stop="50523196" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604004" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2873522" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_015166.3:c.135dupC|Megalencephalic leukoencephalopathy with subcortical cysts" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001458247" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.3:c.135dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Megalencephalic leukoencephalopathy with subcortical cysts</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3098084" SubmissionDate="2021-05-05" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_139202.3:c.135dupC|OMIM:604004" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001573208" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India" OrgID="505991" OrganizationCategory="laboratory" OrgAbbreviation="KMC-MAHE" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next Generation Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Mendeliome</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_139202.3:c.135dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604004" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9585180</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7339015" SubmissionDate="2023-05-22" DateLastUpdated="2023-05-27" DateCreated="2023-05-27">
        <ClinVarSubmissionID localKey="SUB13429850" submittedAssembly="hg19" title="SUB13429850" />
        <ClinVarAccession Accession="SCV003925691" DateUpdated="2023-05-27" DateCreated="2023-05-27" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">21555057</ID>
          </Citation>
          <Comment>A Homozygote Frameshift variant c.135dupC in Exon 2 of the MLC1 gene that results in the amino acid substitution p.Cys46fs*34 was identified. The observed variant has a minor allele frequency of 0.00003% in gnomAD exomes and and novel in 1KG, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease- causing. ClinVar has also classified this variant as Pathogenic [Variation ID: 4722]. The observed variation has been previously reported in individuals with megalencephalic leukoencephalopathy (Shukla P, et.al., 2011). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1">
              <Name>modulator of VRAC current 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_015166.4:exon 2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs80358241" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.4:c.135dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604004" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13429850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1857882" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4964362|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000963504" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11254442</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16470554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24824219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11935341</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12189496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21555057</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys46Leufs*34) in the MLC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MLC1 are known to be pathogenic (PMID: 11254442, 16470554, 24824219). This variant is present in population databases (rs80358241, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with megalencephalic leukoencephalopathy (PMID: 11935341, 12189496, 21555057). ClinVar contains an entry for this variant (Variation ID: 4722). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.50523196_50523197insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842253" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_015166.4:c.135dup|OMIM:604004" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194971" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015166.4:c.135dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604004" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2873522" TraitType="Disease" MappingType="Name" MappingValue="Megalencephalic leukoencephalopathy with subcortical cysts" MappingRef="Preferred">
        <MedGen CUI="C1858854" Name="Megalencephalic leukoencephalopathy with subcortical cysts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25163" TraitType="Disease" MappingType="Name" MappingValue="MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1" MappingRef="Preferred">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3098084" TraitType="Disease" MappingType="XRef" MappingValue="604004" MappingRef="OMIM">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7125644" TraitType="Disease" MappingType="XRef" MappingValue="604004" MappingRef="OMIM">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7339015" TraitType="Disease" MappingType="XRef" MappingValue="604004" MappingRef="OMIM">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41274" TraitType="Disease" MappingType="XRef" MappingValue="CN034246" MappingRef="MedGen">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354508" TraitType="Disease" MappingType="XRef" MappingValue="604004" MappingRef="OMIM">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1857882" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842253" TraitType="Disease" MappingType="XRef" MappingValue="604004" MappingRef="OMIM">
        <MedGen CUI="C5779875" Name="Megalencephalic leukoencephalopathy with subcortical cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1390393" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

